Who is the owner of Grifols?
Raimon Grifols Roura
Today, Grifols is among three companies that dominate the global plasma market. It remains a family business, run by co-chief executive officers Raimon Grifols Roura, the son of co-founder Victor, and his nephew, Victor Grifols Deu.
Who is the largest plasma company?
Together, the largest three companies (CSL Plasma, Grifols and BioLife (Shire) collect over 75% of the total U.S. source plasma for fractionation.
How much is the company Grifols worth?
Market cap: $10.06 Billion As of December 2021 Grifols has a market cap of $10.06 Billion. This makes Grifols the world’s 1565th most valuable company by market cap according to our data.
How big is grifols?
Grifols
| Type | Sociedad Anónima |
|---|---|
| Total assets | €9.601 billion (2015) €8,449.7 million (2014) |
| Total equity | €3.3014 billion (2015) €2,662.9 million (2014) |
| Number of employees | 21,500 (2019, average) |
| Website |
Who owns Talecris?
Grifols GRLS.
MADRID (Reuters) – Spain’s Grifols GRLS.MC has agreed to buy U.S.-based Talecris Biotherapeutics TLCR. O, which makes plasma-based protein medicines, for $3.4 billion in a bold move to expand its business in blood-derived products.
What drugs make grifols?
Grifols is the major world supplier of IVIG, albumin, Factor VIII and other plasma-derived products.
How many plasma centers does grifols own?
344 plasma centers
Grifols now operates 344 plasma centers worldwide: 289 in the U.S. and 55 in Europe across Germany, Austria and, recently Hungary.
Is grifols privately owned?
Today, Grifols is one of just three companies that dominate the global plasma market. It is still a family business run by co-CEOs Raimon Grifols Roura, the son of co-founder Victor and his nephew Victor Grifols Deu.
